Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001070081-17-000113
Filing Date
2017-07-03
Accepted
2017-07-03 16:24:22
Documents
5
Period of Report
2017-04-20
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A form8-ka42017.htm 8-K/A 32303
2 EXHIBIT 23.1 form8-ka42017xexhibit231.htm EX-23.1 2682
3 EXHIBIT 99.2 form8-ka42017xexhibit992.htm EX-99.2 210422
4 EXHIBIT 99.3 form8-ka42017xexhibit993.htm EX-99.3 240107
5 EXHIBIT 99.4 form8-ka42017xexhibit994.htm EX-99.4 293107
  Complete submission text file 0001070081-17-000113.txt   779768
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35969 | Film No.: 17945567
SIC: 2834 Pharmaceutical Preparations